HOME
＞ Shareholders' Meeting
Consolidated Earnings Briefing
Annual Report
Consolidated Financial Results
History
Press Release
Shareholders' Meeting
Research & Development Division
R&D Pipeline
Major Products
Licensing Opportunities
Overseas Activity
Map
To read the PDF files you will need Adobe Reader.
The 92nd Ordinary General Meeting of Shareholders
Notice of Convocation
Copyright(C) Kaken Pharmaceutical Co.,Ltd. All Rights Reserved.
